Literature DB >> 22247823

Challenges in the differential diagnosis of hypercalcemia: A case of hypercalcemia with normal PTH level.

Francesca Pellicciotti1, Andrea Giusti, Maria Carolina Gelli, Salvatore Foderaro, Alberto Ferrari, Giulio Pioli.   

Abstract

The hypercalcemias are a common and heterogeneous group of disorders, ranging from the occasional detection of a high level of serum calcium to a life-treating condition. In a patient presenting with hypercalcemia, a differential diagnosis can be established easily by measuring serum calcium and parathyroid hormone (PTH) concentrations. We describe the case of an 83-year-old man presenting with a severe symptomatic hypercalcemia with high-normal PTH level due to the coexistence of primary hyperparathyroidism and malignancy-associated hypercalcemia. The presence of two conditions producing hypercalcemia was revealed only during in-hospital stay and after the administration of an intravenous bisphosphonate, when the PTH concentration increased rapidly after bisphosphonate treatment with a decrease in serum calcium. The occurrence of two conditions producing hypercalcemia is a rare event in the literature, and should be considered in the presence of an abnormally high serum calcium level associated with normal or high-normal PTH, in order to establish a correct diagnosis and appropriate interventions.

Entities:  

Keywords:  Bisphosphonates; Hypercalcemia; Malignancy-associated hypercalcemia; Parathyroid hormone; Primary hyperparathyroidism

Year:  2012        PMID: 22247823      PMCID: PMC3257349          DOI: 10.5306/wjco.v3.i1.7

Source DB:  PubMed          Journal:  World J Clin Oncol        ISSN: 2218-4333


  10 in total

1.  Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency.

Authors:  Andrea Giusti; Antonella Barone; Giulio Pioli; Giuseppe Girasole; Monica Razzano; Monica Pizzonia; Mario Pedrazzoni; Ernesto Palummeri; Gerolamo Bianchi
Journal:  J Am Geriatr Soc       Date:  2010-07-14       Impact factor: 5.562

Review 2.  Disorders involving calcium, phosphorus, and magnesium.

Authors:  Sharon M Moe
Journal:  Prim Care       Date:  2008-06       Impact factor: 2.907

Review 3.  Medical management of primary hyperparathyroidism with concomitant multiple myeloma.

Authors:  Zaher Fanari; Huseyin Kadikoy; Waqar Haque; Omar Pacha; Abdul Abdellatif
Journal:  Intern Med       Date:  2010-03-15       Impact factor: 1.271

4.  Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency.

Authors:  O Sahota; M K Mundey; P San; I M Godber; D J Hosking
Journal:  Osteoporos Int       Date:  2006-04-05       Impact factor: 4.507

5.  Sarcoid granulomas in the parathyroid gland - a case of dual pathology: hypercalcaemia due to a parathyroid adenoma and coexistent sarcoidosis with granulomas located within the parathyroid adenoma and thyroid gland.

Authors:  Anjali Balasanthiran; Belinda Sandler; Kwamena Amonoo-Kuofi; Rajiv Swamy; Sunil Kaniyur; Felicity Kaplan
Journal:  Endocr J       Date:  2010-06-15       Impact factor: 2.349

Review 6.  Evaluation of hypercalcemia in relation to hyperparathyroidism.

Authors:  Phillip K Pellitteri
Journal:  Otolaryngol Clin North Am       Date:  2010-04       Impact factor: 3.346

7.  Persistent secondary hyperparathyroidism after renal transplantation.

Authors:  P Messa; C Sindici; G Cannella; V Miotti; A Risaliti; M Gropuzzo; P L Di Loreto; F Bresadola; G Mioni
Journal:  Kidney Int       Date:  1998-11       Impact factor: 10.612

Review 8.  Medical treatment of hypercalcaemia.

Authors:  Polyzois Makras; Socrates E Papapoulos
Journal:  Hormones (Athens)       Date:  2009 Apr-Jun       Impact factor: 2.885

9.  Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency.

Authors:  R K Rude; S B Oldham; F R Singer
Journal:  Clin Endocrinol (Oxf)       Date:  1976-05       Impact factor: 3.478

10.  Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with clear cell endometrial cancer.

Authors:  Daniel S Richey; Brian J Welch
Journal:  South Med J       Date:  2008-12       Impact factor: 0.954

  10 in total
  2 in total

1.  Man of Steel Syndrome: Silicone and Mineral Oil Injections With Associated Hypercalcemia, Hypophosphatemia, and Proximal Muscle Weakness.

Authors:  Arash Shirvani; Nadine E Palermo; Michael F Holick
Journal:  JBMR Plus       Date:  2019-07-29

2.  Hypercalcemia of Malignancy Attributed to Cosecretion of PTH and PTHRP in Lung Adenocarcinoma.

Authors:  Jeffrey M Kroopnick; Ubaldo Martinez-Outschoorn; Madalina Tuluc; Caroline S Kim
Journal:  AACE Clin Case Rep       Date:  2021-01-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.